Search

everythinglearnresearchcommunity

for

Search:↓

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Using finasteride may increase the risk of erectile dysfunction.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

More research needed to confirm finasteride as standard treatment for FFA.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

The document discusses new insights into how hormones affect male sexual health and related conditions.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Male pattern baldness may be linked to prostate cancer risk.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.